Jason Freed, MD

Freed outlines which patients should proceed directly to IV iron without a trial of oral therapy and why oral iron follow-up is inadequately practiced in the United States.

Freed discusses how to select among IV iron formulations based on practical and access considerations.

Freed discusses the evidence supporting treatment of iron deficiency before anemia develops, the symptom burden of non-anemic iron deficiency including fatigue, restless legs syndrome, and pica.

Freed explains why iron deficiency anemia is being missed at an alarming rate in clinical practice and what the ASH draft guidelines propose to correct this systemic failure.